Key result
Higher METS-IR is linked to ~10% greater insulin resistance risk, outperforming TyG and TG/HDL-C.
Why the study?
Traditional noninvasive metabolic surrogate markers developed for adults show inconsistent performance and limited applicability for identifying insulin resistance and MASLD during puberty in adolescents.
Does METS-IR provide better discriminative performance for identifying insulin resistance and MASLD in adolescents compared to the TyG index and TG/HDL-C ratio?
Cross-Sectional (n=257)
Does METS-IR provide better discriminative performance for identifying insulin resistance and MASLD in adolescents compared to the TyG index and TG/HDL-C ratio?
Odds Ratio: 1.1 (95% CI 1.025–1.18)
METS-IR demonstrates superior discriminative performance for identifying insulin resistance in adolescents compared to conventional metabolic indices, offering a potentially more accurate noninvasive metabolic surrogate marker during puberty.
The prevalence of insulin resistance (IR) and metabolic dysfunction-associated steatotic liver disease (MASLD) has risen markedly among children and adolescents in recent years. Traditional noninvasive metabolic surrogate markers developed for adult populations have shown inconsistent performance and limited applicability during puberty. To compare the discriminative performance of the metabolic score for insulin resistance (METS-IR), the triglyceride-glucose (TyG) index, and the TG/HDL-C ratio in identifying IR and MASLD among adolescents. This cross-sectional study included 257 adolescents aged 10–18 years. The discriminative value of various metabolic indices for IR and MASLD was evaluated using receiver operating characteristic (ROC) curve analysis, multivariate logistic regression, and Spearman correlation analysis. For IR identification, METS-IR demonstrated the most effective discriminative ability, with an area under the curve (AUC) of 0.736 and an optimal cutoff of 46.68 (sensitivity 52.9%, specificity 94.7%). Conversely, neither the TyG index (AUC = 0.550) nor the TG/HDL-C ratio (AUC = 0.516) reached statistical significance. For MASLD identification, all three indices showed significant discriminative value, with METS-IR remaining the highest numerical AUC (AUC = 0.705; optimal cutoff value: 42.60; sensitivity: 75.8%; specificity: 57.6%), although DeLong’s test showed no significant difference from the TyG index ( P = 0.524). The AUCs for the TyG index and the TG/HDL-C ratio were 0.669 and 0.631, respectively. After adjusting for age, sex, and other potential confounders, multivariate logistic regression showed that METS-IR remained independently associated with both IR (OR = 1.100, 95% CI 1.025–1.180) and MASLD (OR = 1.087, 95% CI 1.014–1.165). METS-IR demonstrated better discriminative performance in identifying IR and MASLD in adolescents than conventional metabolic indices such as the TyG index and the TG/HDL-C ratio. Integrating adiposity and glycolipid metabolic parameters may enhance the ability of METS-IR to reflect the metabolic characteristics of puberty. These findings warrant further prospective validation in general adolescent populations prior to clinical application.
No takes yet. Share an insight, caveat, or question.
Su et al. (2026) conducted a cross-sectional in Insulin resistance and metabolic dysfunction-associated steatotic liver disease (MASLD) (n=257). METS-IR vs. TyG index and TG/HDL-C ratio was evaluated on Insulin resistance (OR 1.100, 95% CI 1.025-1.180). METS-IR was independently associated with insulin resistance (OR 1.100; 95% CI 1.025-1.180) and MASLD, demonstrating better discriminative ability than the TyG index and TG/HDL-C ratio.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: